The Group has a consolidated Cell Captive, used as an investment to fund Telkom’s post-retirement medical aid liability.
The earnings from the Cell Captive are recognised in profit or loss and then transferred to non-distributable reserves.
The available-for-sale investment is a re-insurance premium of the Cell Captive recognised directly in equity.